Please provide your email address to receive an email when new articles are posted on . Before the pandemic, 34.5% of patients with disabilities and end-stage kidney disease transitioned to home ...

The University of Alabama at Birmingham (UAB) Kidney-Pancreas Transplant faculty have busy elective dialysis access practices. Almost 1,000 operative cases are performed each year. A strong emphasis ...

A new device for the percutaneous creation of an arteriovenous fistula (AVF) for hemodialysis access in patients with kidney disease has excellent cumulative patency rates out to 2 years and is ...

Autologous arteriovenous access is the key to long-term success with hemodialysis and is strongly supported by the National Kidney Foundation's Dialysis Outcomes Quality Initiative guidelines. Basilic ...

Patients with kidney failure must often have hemodialysis one or more times each week to assist their kidneys in filtering waste products out of their blood streams. The dialysis filtering process ...

The Society of Interventional Radiology (SIR) published new practice guidance for the creation of percutaneous arteriovenous fistulas (pAVFs) for dialysis access. The guidance was published online in ...

A heparin-coated endovascular prosthesis has received approval from the US Food and Drug Administration (FDA) for treatment of stenosis or thrombotic occlusions at the venous anastomosis of synthetic ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO – Placing an access in a dialysis patient is the beginning of a long road. How do you maintain strong ...

Access to dialysis care remains a life-or-death issue for the nearly 520,000 Americans currently on dialysis, according to National End Stage Renal Disease Census data. While the United States has ...

DURHAM, N.C., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...

Despite all the progress achieved since Scribner first introduced the arteriovenous (AV) shunt in 1960 and Cimino and Brescia introduced the native AV fistula in 1962, we have continued to face a ...